BEBT-507_Guangzhou BeBetter Medicine Technology Co, LTD.

BEBT-507

BEBT-507 is the company's first small nucleic acid (siRNA) drug designed and discovered in-house. It holds the potential to become a First-in-Class drug for the treatment of iron regulation disorders. Currently, it has entered the IND-enabling trial stage.

Home Page
About Us
Innovation Science
Science & Pipeline
Press Releases
Career
Contact Us